AI Summary
Tuberculosis is still a major global health problem, especially in low-income and middle-income countries. The disease is becoming resistant to drugs, there are limited treatment options, and funding is not sufficient to combat it effectively.
Tuberculosis remains one of the deadliest infectious diseases in the world, particularly in low-income and middle-income countries. An estimated global total of 10·6 million people fell ill with the disease and 1·6 million succumbed to it in 2021. The rise of multidrug-resistant and extensively drug-resistant tuberculosis, together with slow development of new drugs and vaccines, co-infection with HIV, a partially effective vaccine, and stagnant funding, continue to impede the fight against this disease.